Moussa Doumbia

Generating author description...

All published works

Action	Title	Year	Authors
+	Long-term cellular immunity of vaccines for Zaire Ebola Virus Diseases	2024	Aurélie Wiedemann Édouard Lhomme Mélanie Huchon Emile Foucat Marion Bérerd-Camara Lydia Guillaumat Marcel Yaradouno Jacqueline Tambalou Cécile Rodrigues Alexandre Lima de Araújo Ribeiro
+	Impact of follow ups, time interval and study duration in diffusion & myelin MRI clinical study in MS	2023	Manon Edde Francis Houde Guillaume Theaud Matthieu Dumont Guillaume Gilbert Jean‐Christophe Houde Loïka Maltais Antoine Théberge Moussa Doumbia Ann‐Marie Beaudoin
+ PDF Chat	Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial	2015	Ana María Henao-Restrepo Ira M. Longini Matthias Egger Natalie E. Dean W. John Edmunds Anton Camacho Miles W. Carroll Moussa Doumbia Bertrand Draguez Sophie Duraffour

Common Coauthors

Coauthor	Papers Together
Natasha Howard	1
Papa Ndiaga Cissé	1
Fatoumata Diallo	1
Kelly Cahill	1
Éric D’Ortenzio	1
David Ishola	1
Augustin Augier	1
Bockarie Koroma	1
Aurélie Wiedemann	1
Moses Massaquoi	1
Dickens Kowuor	1
Alain DuChêne	1
Yazdan Yazdanpanah	1
Nelson Dozier	1
Bruce Thompson	1
Aminata Bagayoko	1
Hilary Whitworth	1
Rita Lukoo Ndamenyaa	1
Mandy Kader Kondé	1
Robert Akpata	1
Babajide Keshinro	1
John McCullough	1
Teedoh Beyslow	1
Sibiry Samake	1
Beth Baseler	1
Richard Kojan	1
Julia Lysander	1
Tijili Tyee	1
Barbara Cagniard	1
Francois Chambelin	1
Soumaya Mohamed	1
Amy Falk Russell	1
David Vallée	1
Ydrissa Sow	1
Steven Mazur	1
Michael J. Stirratt	1
Maxime Schvartz	1
Melvin Johnson	1
Brian Köhn	1
Courtney Lambeth	1
Benjamin Hamzé	1
Yusupha Njie	1
Bolarinde Lawal	1
Melissa E. Hughes	1
Natasha Dubois Cauwelaert	1
Cynthia Robinson	1
Shuǐqìng Yú	1
Yvonne Jato	1
Édouard Lhomme	1
Benetta C. Andrews	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+	Cluster Randomised Trials	2009	Eva Batistatou	1
+	Design and Analysis of Cluster Randomization Trials in Health Research	2000	Allan Donner Neil Klar	1
+ PDF Chat	The control of the false discovery rate in multiple testing under dependency	2001	Yoav Benjamini Daniel Yekutieli	1
+	Linear Models in Statistics	2007	Alvin C. Rencher G. Bruce Schaalje	1
+	Design and Analysis of Cluster Randomization Trials in Health Research	2001	William W. Davis	1
+	A Multiple Testing Procedure for Clinical Trials	1979	Peter C. O’Brien Thomas R. Fleming	1
+ PDF Chat	Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses	2009	Franz Faul Edgar Erdfelder Axel Buchner Albert-Georg Lang	1
+	Subverting Randomization in Controlled Trials	1995	Kenneth F. Schulz	1
+	Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing	1995	Yoav Benjamini Yosef Hochberg	1
+	Regression Shrinkage and Selection Via the Lasso	1996	Robert Tibshirani	1
+	Longitudinal data analysis using generalized linear models	1986	Kung‐Yee Liang Scott L. Zeger	1
+ PDF Chat	A Recombinant Vesicular Stomatitis Virus Ebola Vaccine	2015	Jason A. Regules John H. Beigel Kristopher Paolino Jocelyn Voell Amy R. Castellano Zonghui Hu P. Rubio Muñoz James E. Moon Richard C. Ruck Jason W. Bennett	1
+	Design and Analysis of Vaccine Studies	2009	M. Elizabeth Halloran Ira M. Longini Claúdio J. Struchiner	1
+ PDF Chat	Dynamics of Ebola RNA Persistence in Semen: A Report From the Postebogui Cohort in Guinea	2017	Fabien Subtil Charlotte Lanièce Delaunay Alpha Kabinet Keïta Mamadou Sow Abdoulaye Touré Sandrine Leroy Philippe Msellati N’Fally Magassouba Sylvain Baize Hervé Raoul	1
+	Correlates of vaccine-induced protective immunity against Ebola virus disease	2018	Donata Medaglini Francesco Santoro Claire‐Anne Siegrist	1
+ PDF Chat	Long-lasting severe immune dysfunction in Ebola virus disease survivors	2020	Aurélie Wiedemann Emile Foucat Hakim Hocini Cécile Lefebvre Boris P. Hejblum Mélany Durand Miriam Krüger Alpha Kabinet Keïta Ahidjo Ayouba Stéphane Mély	1
+ PDF Chat	Ebola Virus Disease Survivors Show More Efficient Antibody Immunity than Vaccinees Despite Similar Levels of Circulating Immunoglobulins	2020	Till Koch Monika Rottstegge Paula Ruibal Sergio Gómez‐Medina Emily V. Nelson Beatriz Escudero-Pérez Matthias Pillny My Linh Ly Fara Raymond Koundouno Joseph Akoi Boré	1
+ PDF Chat	Understanding Long-term Evolution and Predictors of Sequelae of Ebola Virus Disease Survivors in Guinea: A 48-Month Prospective, Longitudinal Cohort Study (PostEboGui)	2021	Mamadou Saliou Kalifa Diallo Abdoulaye Touré Mamadou Sow Cécé Kpamou Alpha Kabinet Keïta Bernard Taverne Martine Peeters Philippe Msellati Thierno Alimou Barry Jean-François Étard	1
+	A three-time point longitudinal investigation of the arcuate fasciculus throughout reading acquisition in children developing dyslexia	2021	Stijn Van Der Auwera Maaike Vandermosten Jan Wouters Pol Ghesquière Jolijn Vanderauwera	1
+ PDF Chat	Growth mixture models: a case example of the longitudinal analysis of patient‐reported outcomes data captured by a clinical registry	2021	Jae‐Yung Kwon Richard Sawatzky Jennifer Baumbusch Sandra Lauck Pamela A. Ratner	1
+ PDF Chat	Temporal evolution of the humoral antibody response after Ebola virus disease in Guinea: a 60-month observational prospective cohort study	2021	Mamadou Saliou Kalifa Diallo Ahidjo Ayouba Alpha Kabinet Keïta Guillaume Thaurignac Mamadou Sow Cécé Kpamou Thierno Alimou Barry Philippe Msellati Jean-François Étard Martine Peeters	1
+ PDF Chat	Ebola Virus Disease among Children in West Africa	2015		1
+ PDF Chat	Ebola Virus Disease in West Africa — The First 9 Months of the Epidemic and Forward Projections	2014		1
+	Development of the PREDS score to predict in-hospital mortality of patients with Ebola virus disease under advanced supportive care: Results from the EVISTA cohort in the Democratic Republic of the Congo	2022	Marie Jaspard Sabue Mulangu Sylvain Juchet Béatrice Serra Ibrahim Dicko Hans-Joeg Lang Baweye Mayoum Baka Gaston Musemakweli Komanda Jeremie Muhindo Katsavara Patricia Kabuni	1
+ PDF Chat	Randomized Trial of Vaccines for Zaire Ebola Virus Disease	2022	Mark Kieh Laura Richert Abdoul Habib Béavogui Birgit Grund Bailah Leigh Éric D’Ortenzio Seydou Doumbia Edouard Lhomme Samba O. Sow Renaud Vatrinet	1
+ PDF Chat	Persistence of immunological memory as a potential correlate of long-term, vaccine-induced protection against Ebola virus disease in humans	2023	Chelsea McLean Karin Dijkman Auguste Gaddah Babajide Keshinro Michael Katwere Macaya Douoguih Cynthia Robinson Laura Solforosi Dominika N. Czapska-Casey Liesbeth Dekking	1
+ PDF Chat	Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability	2023	Angela Huttner Sélidji Todagbé Agnandji Olivier Engler Jay W. Hooper Steve Kwilas Keersten M. Ricks Tamara L. Clements Hulda R. Jónsdóttir Sravya Sowdamini Nakka Sylvia Rothenberger	1
+	Case fatality risk among individuals vaccinated with rVSVΔG-ZEBOV-GP: a retrospective cohort analysis of patients with confirmed Ebola virus disease in the Democratic Republic of the Congo	2024	Rebecca M. Coulborn Mathieu Bastard Nicolas Peyraud Etienne Gignoux Francisco J. Luquero Bérengère Guai Stéphane Hans Bateyi Mustafa Elisabeth Mukamba Musenga Steve Ahuka‐Mundeke	1
+	Survival and Event History Analysis: A Process Point of View	2008	Odd O. Aalen Oernulf Borgan Håkon K. Gjessing	1